Promotie onderzoek

We will study compounding medication by 3D printing technology. In this way personalized medication will become more accessable. 
First formulation studies will be executed in order to provide a stable production process. After which, the use of 3D printing will be introduced in the clinical setting. Finally, the printed medication will be tested by a clinical trial.
 

We aim to develop models for sepsis detection and therapeutic treatment personalization, using mechanistic modelling and ML/AI approaches.
 

The aim is to improve the therapeutic drug monitoring process using drug dosing software and new laboratory techniques.
 

Evaluation of hybrid care paths with Home Blood Pressure Telemonitoring through a quintiple aim perspective (clinical efficiency, cost-effectiveness, healthcare provider experience, patient experience and health equity).
 

We aim to develop methods to radiolabel orally inhaled drug products, allowing us to more accurately determine lung deposition through imaging techniques. 
 

To describe the impact of COVID-19 on the continuity of care in the primary care setting.
To describe the impact of delirium and frailty on clinical outcomes in COVID-19 patients admitted to the hospital.
To describe the impact of delirium on recovery of COVID-19 patients in geriatric rehabilitation.
To describe perceptions, motivations, needs and experiences of geriatricians with scientific research.
 

My research focuses on therapeutic drug monitoring of antipsychotics in children with an autism spectrum disorder, and adolescents with anorexia nervosa.